 |  | 

Effects of methylcobalamin on the proliferation of androgen-sensitive or
estrogen-sensitive malignant cells in culture and in vivo.
Nishizawa Y, Yamamoto T, Terada N, Fushiki S, Matsumoto K, Nishizawa Y
Department of Pathology, Osaka Medical Center for Cancer, Japan.
Methylcobalamin is one of the coenzymatically active cobalamin derivates and
required for the activity of the cytoplasmic enzyme methionine synthetase
catalyzing the methylation of homocysteine into methionine.
The effect of
methylcobalamin on the proliferation of malignant cells has been examined.
Methylcobalamin inhibited the proliferation of androgen-sensitive SC-3 cells
(a cloned cell line from Shionogi mouse mammary tumor, SC115) in culture at
the concentration of 100-300 micrograms/ml. An inhibitory activity of
methylcobalamin on the proliferation was also observed in other cell lines
(estrogen-sensitive B-1F cells from mouse Leydig cell tumor and MCF-7 cells
from human mammary tumor) at the concentration of 500 micrograms/ml.
Moreover, large doses of methylcobalamin injected intraperitoneally (100
mg/kg body weight/day) were non-toxic and suppressed the tumor growth of
SC115 and B-1F cells in mice fed a vitamin B12 deficient diet.
These results
show that methylcobalamin inhibits the proliferation of malignant cells in
culture and in vivo and propose the possibility of methylcobalamin as a
candidate of potentially useful agents for the treatment for some malignant
tumors.
PMID: 9202976, UI: 97346559
|
 |  |  | 
 JNCI,7/02

|  |  |  | 
 Am J of Hematology, 8/02

|  |
Remember we are NOT Doctors and have NO medical training.
This site is like an Encylopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM. |
|